Quanxing Ni
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 5%
- Topics
- Pancreatic and Hepatic Oncology Research (96 papers)Neuroendocrine Tumor Research Advances (40 papers)Pancreatitis Pathology and Treatment (25 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Quanxing Ni
139 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 3.2k
- Molecular Biology 2.5k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 1.1k
- Surgery 1.0k
Countries citing papers authored by Quanxing Ni
This map shows the geographic impact of Quanxing Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanxing Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanxing Ni more than expected).
Fields of papers citing papers by Quanxing Ni
This network shows the impact of papers produced by Quanxing Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanxing Ni. The network helps show where Quanxing Ni may publish in the future.
Co-authorship network of co-authors of Quanxing Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Quanxing Ni. A scholar is included among the top collaborators of Quanxing Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanxing Ni. Quanxing Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 231 | |
| 4 | 30 | |
| 5 | 17 | |
| 6 | The role of necroptosis in cancer biology and therapybreakdown → | 782 |
| 7 | 53 | |
| 8 | 23 | |
| 9 | 63 | |
| 10 | 46 | |
| 11 | O-6-Methylguanine-DNA Methyltransferase and Response to Alkylation Agents in Neuroendocrine Tumor: A Meta-Analysis | 2 |
| 12 | 26 | |
| 13 | 50 | |
| 14 | 76 | |
| 15 | 54 | |
| 16 | 48 | |
| 17 | 45 | |
| 18 | 13 | |
| 19 | Clinico-pathological characteristics and influencing factors of lymph node metastasis of pancreatic head carcinoma | 1 |
| 20 | The expression of serum IL-6, IL-10, IL-12 level in gastrointestinal neoplasm and its significance | 0 |
About Quanxing Ni
Quanxing Ni is a scholar working on Oncology, Cancer Research and Epidemiology, having authored 141 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (96 papers), Neuroendocrine Tumor Research Advances (40 papers) and Pancreatitis Pathology and Treatment (25 papers). The work is most often cited by research in Oncology (3.2k citations), Cancer Research (1.7k citations) and Molecular Biology (2.5k citations). Quanxing Ni has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Xianjun Yu, Chen Liu, Guopei Luo, Jin Xu, Kaizhou Jin, Jiang Long, Zhiyao Fan, Yitao Gong, Qiuyi Huang and Shunrong Ji. Their work appears in journals such as PLoS ONE, Cancer Research and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.